Pancreatic Cancer Research

ResearcherUniversité Libre de BruxellesActive in the last 2 years

Matthieu Hein

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0003-4243-1653; OpenAlex author ID A5012796065. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. Co-author DOI 10.1038/s41416-025-03274-0↗
  2. Suicide Risk and Associated Factors in Patients with Pancreatic Cancer: A Systematic Review. Last author DOI 10.3390/diseases14090346↗
  3. Impact of Depression on Mortality in Patients with Pancreatic Cancer: A Systematic Review. Co-author DOI 10.3390/curroncol32090511↗
  4. Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body Radiotherapy Co-author DOI 10.1101/2024.04.30.591890↗
  5. Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Eval… Co-author DOI 10.3390/cancers14235730↗
  6. Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenoc… Co-author DOI 10.1177/17588359211045860↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christelle Bouchart · 6 shared papers, 2021–2026 · strength 1.68
  2. Julie Navez · 4 shared papers, 2021–2026 · strength 0.64
  3. Jean-Luc Van Laethem · 4 shared papers, 2021–2026 · strength 0.64
  4. Maxence Chicoisneau · 1 shared paper, 2026 · strength 0.50
  5. Léo Mas · 2 shared papers, 2024–2026 · strength 0.38
  6. Pieter Demetter · 2 shared papers, 2024–2026 · strength 0.38
  7. Rémy Nicolle · 2 shared papers, 2024–2026 · strength 0.38
  8. Nicky D’Haene · 2 shared papers, 2024–2026 · strength 0.38
  9. Shulin Zhao · 2 shared papers, 2024–2026 · strength 0.38
  10. Oier Azurmendi Senar · 2 shared papers, 2024–2026 · strength 0.38
  11. Kosta Stosic · 2 shared papers, 2024–2026 · strength 0.38
  12. Ilse Rooman · 2 shared papers, 2024–2026 · strength 0.38
  13. Jean-Baptiste Bachet · 2 shared papers, 2024–2026 · strength 0.38
  14. Tatjana Arsenijevic · 2 shared papers, 2024–2026 · strength 0.38
  15. Jean Closset · 2 shared papers, 2021–2022 · strength 0.26
  16. Maria Antonietta Bali · 2 shared papers, 2021–2022 · strength 0.26
  17. Ellis Michiels · 1 shared paper, 2026 · strength 0.22
  18. Martin Manderlier · 1 shared paper, 2022 · strength 0.15
  19. Alain Hendlisz · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.